Boutros Cherif, Ryan Kristin, Katz Steven, Espat N Joseph, Somasundar Ponnandai
Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Am Surg. 2011 Nov;77(11):1526-30.
Laparoscopic distal pancreatectomy (LDP) has emerged as the procedure of choice for selected patients. This study is to evaluate the feasibility of LDP and procedural outcomes in a series of consecutive nonselected patients. All patients undergoing distal pancreatectomy over 18 months were identified from a prospectively maintained database, under institutional review board approval. A completely laparoscopic (non hand-assisted) procedure was performed using a 4-trocar technique. Conversion to an open procedure, operative time (OR), estimated blood loss (EBL), transfusion requirements, postoperative length of stay (LOS), and complications were assessed. Sixteen patients were identified; 2/16 patients had undergone distal pancreatectomy as a component of another multiorgan open procedure, and were thus excluded. The remaining 14 patients had consented for LDP. Conversion occurred in 4/14 cases. Converted patients trended towards increased OR, EBL, and LOS (P = not significant). No mortalities occurred, and overall morbidities included: pancreatic fistula (n = 2), splenic abscess (n = 1), and pneumonia (n = 1). LDP-splenectomy (n = 3/14) was associated with both increased EBL (683 mL ± 388 vs 168 ± 141, P < 0.002) and increased transfusion rate (3/3 vs 3/11, P = 0.05), as compared with LDP-splenic preservation. LDP with splenic artery preservation (LDP-SAP) was completed in 7 of 14 patients, with less OR (2 hours 29 minutes ± 53 minutes vs 3 hours 40 minutes ± 1 hour, P < 0.05), a decreased transfusion rate (14% vs 71%, P = 0.05), and decreased LOS (2.8 days vs 6.8 days, P = 0.002) compared with LDP without SAP. Pathology was intraductal papillary mucinous neoplasm (IPMN) (n = 5), ductal carcinoma (n = 3), high grade dysphasia (n = 2), neuroendocrine tumor (n = 2), and pancreatitis (n = 2). Patients undergoing LDP-SAP demonstrated superior peri-procedural outcomes. This series of nonselected consecutive patients supports that LDP is technically feasible with a comparable procedural outcome to the selected-patient literature, suggesting potentially expanded indications for LDP.
腹腔镜远端胰腺切除术(LDP)已成为特定患者的首选手术方式。本研究旨在评估LDP在一系列连续非特定患者中的可行性及手术效果。在机构审查委员会批准下,从一个前瞻性维护的数据库中识别出所有在18个月内接受远端胰腺切除术的患者。采用四孔技术进行完全腹腔镜(非手辅助)手术。评估转为开放手术的情况、手术时间(OR)、估计失血量(EBL)、输血需求、术后住院时间(LOS)及并发症。共识别出16例患者;其中2/16例患者已作为另一项多器官开放手术的一部分接受了远端胰腺切除术,因此被排除。其余14例患者同意接受LDP。14例中有4例发生了中转。中转患者的OR、EBL和LOS有增加趋势(P = 无统计学意义)。无死亡病例,总体并发症包括:胰瘘(n = 2)、脾脓肿(n = 1)和肺炎(n = 1)。与保留脾脏的LDP相比,LDP联合脾切除术(n = 3/14)的EBL增加(683 mL ± 388 vs 168 ± 141,P < 0.002)且输血率增加(3/3 vs 3/11,P = 0.05)。14例患者中有7例完成了保留脾动脉的LDP(LDP - SAP),与未保留脾动脉的LDP相比,其OR更短(2小时29分钟 ± 53分钟 vs 3小时40分钟 ± 1小时,P < 0.05),输血率降低(14% vs 71%,P = 0.05),LOS缩短(2.8天 vs 6.8天,P = 0.002)。病理结果为导管内乳头状黏液性肿瘤(IPMN)(n = 5)、导管癌(n = 3)、高级别发育异常(n = 2)、神经内分泌肿瘤(n = 2)和胰腺炎(n = 2)。接受LDP - SAP的患者围手术期效果更佳。这一系列非特定连续患者支持LDP在技术上是可行的,其手术效果与特定患者的文献相当,提示LDP的适应证可能会扩大。